CN103800407A - Health-care product composition - Google Patents
Health-care product composition Download PDFInfo
- Publication number
- CN103800407A CN103800407A CN201210449019.5A CN201210449019A CN103800407A CN 103800407 A CN103800407 A CN 103800407A CN 201210449019 A CN201210449019 A CN 201210449019A CN 103800407 A CN103800407 A CN 103800407A
- Authority
- CN
- China
- Prior art keywords
- health
- extract
- care product
- panacis quinquefolii
- ferrous lactate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a health-care product composition. The health-care product comprises the following active components in percentage by weight: 40-80 percent of astragalus extract, 25-50 percent of American ginseng extract, 1-10 percent of ferrous lactate, and the balance of auxiliaries. Astragalus membranaceus, American ginseng and other traditional Chinese medicinal materials are scientifically compatible with ferrous lactate, so that the health-care product composition is remarkable in improvement of fatigue resistance, and does not have remarkable side effects.
Description
Technical field
The present invention relates to health product technology field, what be specifically related to is a kind of health product for alleviating physical fatigue.
Background technology
Modern medicine thinks that fatigue is that body transfinites and the function that causes reduces and occur that the state of body discomfort, main manifestations are tired sleepy, can occur degradation simultaneous phenomenon under dizziness, forgetful, sleep quality.The factor relations such as tired generation and energy substance consumption, metabolite accumulation, homeostasis sexual maladjustment, free radical impact are close.Along with the reinforcement of people's health care consciousness, various anti-fatigue products arise at the historic moment, wherein Chinese medicine series products natural with it, safely, the advantage such as have no side effect, day by day receive people's concern, as aweto capsule, Radix Panacis Quinquefolii sheet etc.Therefore, exploitation has the health product of the alleviating physical fatigue of tcm characteristic, not only can make up the deficiency of modern medicine in treatment, the advantage of performance Chinese medicine, and also its suitable crowd's scope is wide, and the market demand is large, has wide market prospect.
Summary of the invention
Object of the present invention is just to provide a kind of health product for alleviating physical fatigue.Not only dialectical prescription, the fundamentally root of relieving fatigue, also combines nutrient, hardening agent homenergic material, to promote antisecosis.
In order to realize the object of the invention, the active component and the weight content thereof that form these health product are: Radix Astragali extract 40-80%, Radix Panacis Quinquefolii extract 25-50%, ferrous lactate 1-10%, remaining is adjuvant.
The present invention preferably material combination is: Radix Astragali extract 60%, Radix Panacis Quinquefolii extract 35%, ferrous lactate 5%, remaining is adjuvant.
In the present invention, Radix Astragali extract is no less than 20% containing astragalus polysaccharides; Radix Panacis Quinquefolii extract total saponin content is no less than 5%.
Compared with prior art, advantage of the present invention is: dialectical prescription in conjunction with nutrient, curative effect is clear and definite.
The Radix Astragali: be the root of leguminous plant Radix Astagali Astragalus memeranaceus (Fisch.) Bge.var.mongholicus (Bge.) Hsiao or Radix Astragali A.membranaceus (Fisch.) Bge..Main product in the Inner Mongol, the ground such as Shanxi, Heilungkiang.Two seasons of spring and autumn excavate, and remove fibrous root and root head, dry section, raw using or processed with honey use.The Radix Astragali can promote the renewal of organism metabolism, resisting fatigue, promotion serum and hepatic protein; There is obvious diuresis, can eliminate Jishengshenqiwan urine protein; Can improve anemia animal phenomenon; The hypoglycemia that can raise, reduces hyperglycemia; Can excitedly breathe; Can strengthen and regulate body's immunity, interferon system is had to facilitation, can improve the premunition of body; The multiple viral institute such as infected by influenza cytopathogenic effect has slight inhibitory action, and influenza virus infected has protective effect; There is antibacterial action more widely; The Radix Astragali, in cell culture, can make cell number showed increased, and Growth of Cells is vigorous, life; Can strengthen myocardial contraction, protection cardiovascular system, anti-arrhythmia, coronary artery dilator and peripheral blood vessel, reduce blood pressure, and can reduce platelet adhesion power, reduces thrombosis; Also have blood fat reducing, defying age, anti-hypoxia, radioprotective, the effect such as protect the liver.
Radix Panacis Quinquefolii: be the root of Araliaceae Radix Panacis Quinquefolii Panax quinquefolium L..Main product is in the U.S., Canada.Also there is cultivation on the ground such as China Beijing, Jilin, Liaoning.Excavate the growth root of 3～6 years autumn, section is raw to be used.Radix Panacis Quinquefolii has Antishock function, can obviously improve hemorrhagic shock rats survival rate; Brain is had to sedation, vital center is had to moderate excitation; Also have anti-hypoxia, resist myocardial ischemia, anti-cardiac muscle oxidation, increase myocardial contraction, arrhythmia, resisting fatigue, anti-stress, convulsion, blood sugar lowering, hemostasis and antidiuretic activity.
Ferrous lactate: this product is ferrum element supplement.Ferrum is the chief component composition of hemoglobin and Myoglobin.Hemoglobin is the person that mainly takes oxygen in erythrocyte, and Myoglobin is the position that muscle cell is stored oxygen, and the needs of oxygen are provided during for muscular movement.With tricarboxylic cycle relevant most of enzymes and the equal iron content of the factor, or only in the time that existing, ferrum just plays a role.Body lacks ferrum, can cause and be short of physical strength etc.
The specific embodiment
The preparation of embodiment 1 capsule of the present invention
Radix Astragali extract 60%, Radix Panacis Quinquefolii extract 35%, ferrous lactate 5%, remaining is adjuvant.
The preparation of embodiment 2 tablets of the present invention
Radix Astragali extract 74%, Radix Panacis Quinquefolii extract 25%, ferrous lactate 1%.Raw material is added to right amount of auxiliary materials, tabletting.
The preparation of embodiment 3 capsules of the present invention
Radix Astragali extract 40%, Radix Panacis Quinquefolii extract 50%, ferrous lactate 10%, remaining is adjuvant.
Claims (3)
1. a Halth-care composition, the active component and the weight content thereof that form these health product are: Radix Astragali extract 40-80%, Radix Panacis Quinquefolii extract 25-50%, ferrous lactate 1-10%, remaining is adjuvant.
2. a kind of Halth-care composition as claimed in claim 1, is characterized in that, the active component and the weight content thereof that form these health product are: Radix Astragali extract 60%, Radix Panacis Quinquefolii extract 35%, ferrous lactate 5%, remaining is adjuvant.
3. a kind of health product for alleviating physical fatigue as described in claim 1-2, is characterized in that, Radix Astragali extract is no less than 20% containing astragalus polysaccharides; Radix Panacis Quinquefolii extract total saponin content is no less than 5%.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210449019.5A CN103800407A (en) | 2012-11-12 | 2012-11-12 | Health-care product composition |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210449019.5A CN103800407A (en) | 2012-11-12 | 2012-11-12 | Health-care product composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103800407A true CN103800407A (en) | 2014-05-21 |
Family
ID=50698102
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201210449019.5A Pending CN103800407A (en) | 2012-11-12 | 2012-11-12 | Health-care product composition |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103800407A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104489814A (en) * | 2014-12-23 | 2015-04-08 | 廖晓兰 | Health coconut juice |
| WO2020098154A1 (en) * | 2018-11-15 | 2020-05-22 | 尤璐库莫有限公司 | Ceratonia siliqua fruit composition and preparation method therefor and use thereof |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101249154A (en) * | 2008-04-09 | 2008-08-27 | 北京市科威华食品工程技术有限公司 | Nourishing blood soothe the nerves oral liquid |
| CN101703623A (en) * | 2009-11-12 | 2010-05-12 | 西安斯强实业有限公司 | Capsule with effect of relieving physical fatigue |
| CN101756185A (en) * | 2008-10-22 | 2010-06-30 | 于树丽 | American ginseng astragalus buccal tablet |
| WO2010143053A1 (en) * | 2009-06-10 | 2010-12-16 | Energy4Life Ag | Methods and compositions for treating insulin resistance, diabetes mellitus type 2, metabolic syndrome and related disorders |
-
2012
- 2012-11-12 CN CN201210449019.5A patent/CN103800407A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101249154A (en) * | 2008-04-09 | 2008-08-27 | 北京市科威华食品工程技术有限公司 | Nourishing blood soothe the nerves oral liquid |
| CN101756185A (en) * | 2008-10-22 | 2010-06-30 | 于树丽 | American ginseng astragalus buccal tablet |
| WO2010143053A1 (en) * | 2009-06-10 | 2010-12-16 | Energy4Life Ag | Methods and compositions for treating insulin resistance, diabetes mellitus type 2, metabolic syndrome and related disorders |
| CN101703623A (en) * | 2009-11-12 | 2010-05-12 | 西安斯强实业有限公司 | Capsule with effect of relieving physical fatigue |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104489814A (en) * | 2014-12-23 | 2015-04-08 | 廖晓兰 | Health coconut juice |
| WO2020098154A1 (en) * | 2018-11-15 | 2020-05-22 | 尤璐库莫有限公司 | Ceratonia siliqua fruit composition and preparation method therefor and use thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101890040B (en) | Composition with anti-fatigue effect and application thereof | |
| CN101972353A (en) | Medicine composition for preventing and treating heart cerebrovascular diseases | |
| CN104706707A (en) | Antiviral immunity-enhancing ginseng healthcare product | |
| CN102579836A (en) | Traditional Chinese medical dendrobium huoshanense composition and preparation method thereof | |
| CN102526276B (en) | Anti-hypertension medicinal composition and preparation method for same | |
| CN103766885A (en) | Health food for alleviating physical fatigue | |
| CN103800407A (en) | Health-care product composition | |
| CN102813728A (en) | Traditional Chinese medicine for treating heart-kidney yang deficiency-type chronic heart failure | |
| CN102048153A (en) | Health-care food with effect of reducing fat and preparation method thereof | |
| CN103564087A (en) | Cordyceps militaris tea | |
| CN103766888A (en) | Preparation containing American ginseng extract | |
| CN103798755A (en) | Anti-fatigue capsule | |
| CN103800548A (en) | Compound traditional chinese medicine | |
| CN103417723A (en) | Linying capsule formula capable of relieving physical fatigue | |
| CN103798771A (en) | Traditional Chinese medicine extract-containing compound preparation | |
| CN103766881A (en) | Traditional Chinese medicine health product | |
| CN103768246A (en) | Traditional Chinese medicine preparation | |
| CN103766887A (en) | Preparation comprising astragalus mongholicus extract | |
| CN103766886A (en) | Astragalus preparation | |
| CN103766882A (en) | Compound astragalus mongholicus preparation | |
| CN103766884A (en) | Novel composite preparation agent | |
| CN103798772A (en) | Health-care product composition | |
| CN103798758A (en) | Preparation containing ginkgo leaf extract | |
| CN103798756A (en) | Traditional Chinese medicine health food | |
| CN108079275A (en) | A kind of health Chinese medicine composition for treating hypertension and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20140521 |